Physician profile
Seth Ramin Ashraf
NPI 1033739735
$17,028.54
in general payments reported to CMS, 2019-2025
10 companies · $16K in 2025
The $16K reported for 2025 was more than what 98% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $67.17 · 2024: $1,016 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $5,124 · Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $5,123.81 |
| Food and Beverage | $1,904.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,331.81 | 2025 | |
| Paragon 28, INC. | $1,899.42 | 2025 | Portfolio |
| Treace Medical Concepts, INC. | $1,473.64 | 2025 | |
| Stryker Corporation | $1,027.68 | 2025 | Infinity Adaptis, Ortholoc 3di, Augment Injectable |
| Medical Device Business Services, INC. | $982.16 | 2024 | |
| Mission Medical Distribution, LLC | $164.02 | 2024-2025 | |
| Kci USA, INC. | $67.17 | 2023 | Activ.A.C., V.A.C.Ulta, Prevena |
| Evolution Surgical, INC | $40.83 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $27.39 | 2025 | |
| Paratek Pharmaceuticals, INC. | $14.42 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Ashraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.